Ann Y. Park

Ann Y. Park

Auto-generated profile, based on publicly available information

Ann Y. Park

Molecular Development of the Immune System Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SKSatoshi Kubo
Satoshi Kubo
JFJill M. Fritz
Jill M. Fritz
HRHayley M. Raquer-McKay
Hayley M. Raquer-McKay
RKRhea Kataria
Rhea Kataria
IVIvan Vujkovic-Cvijin
Ivan Vujkovic-Cvijin
MLMichael J. Lenardo
Michael J. Lenardo

13 May 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YYYikun Yao
Yikun Yao
PJPing Du Jiang
Ping Du Jiang
BCBrittany N. Chao
Brittany N. Chao
DCDeniz Cagdas
Deniz Cagdas
SKSatoshi Kubo
Satoshi Kubo
MLMichael J. Lenardo
Michael J. Lenardo
Inborn errors of immunity (IEIs) unveil regulatory pathways of human immunity. We describe a new IEI caused by mutations in the GTPase of the immune-associated protein 6 (GIMAP6) gene in patients with infections, lymphoproliferation, autoimmunity, and multiorgan vasculitis. Patients and Gimap6−/− mice show defects in autophagy, redox regulation, and polyunsaturated fatty acid (PUFA)–containing lipids. We find that GIMAP6 complexes with GABARAPL2 and GIMAP7 to regulate GTPase activity. Also, GIMAP6 is induced by IFN-γ and plays a critical role in antibacterial immunity. Finally, we observed that Gimap6−/− mice died prematurely from microangiopathic glomerulosclerosis most likely due to GIMAP6 deficiency in kidney endothelial cells.

3 January 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
APAnn Y Park
Ann Y Park
MLMichael Leney-Greene
Michael Leney-Greene
MLMatthew Lynberg
Matthew Lynberg
JGJustin Q Gabrielski
Justin Q Gabrielski
XXXijin Xu
Xijin Xu
MLMichael J Lenardo
Michael J Lenardo

8 June 2026 in Nature
Verified
Journal Article
Open access
JCJing Cui
Jing Cui
ZCZuojia Chen
Zuojia Chen
YCYan H. Cheng
Yan H. Cheng
JNJia Nie
Jia Nie
MZMaria H. Zhu
Maria H. Zhu
MLMichael J. Lenardo
Michael J. Lenardo
Inflammatory bowel disease (IBD) causes chronic suffering from gastrointestinal inflammation and dysfunction that can progress to colon cancer 1,2 . The prevalence of the disease is increasing, and there is an urgent need to better understand its pathogenic mechanisms to improve treatment. We show that GPR15—a G-protein-coupled receptor expressed in immune cells and described previously as an entry co-factor for human and simian immunodeficiency viruses 3 —is a marker and homing receptor for a subset of intramucosal GPR15-guided regulatory CD8 + T lymphocytes (CD8 + T IGR cells). Deleterious GPR15 gene variants in humans cause defective homing of CD8 + T IGR cells and are associated with severe early-onset IBD. Moreover, CD8 + T IGR cells are reduced in the intestinal mucosa of individuals with sporadic IBD. In mice, GPR15 deficiency impairs colonic homing of CD8 + T IGR cells, leading to accumulation of inflammatory macrophages and increased susceptibility to colitis. CD8 + T IGR cells potently kill macrophages activated by intestinal damage or disease using Fas ligand and TNF-related weak inducer of apoptosis (TWEAK). The identification of CD8 + T IGR cells yields new insights into organ-specific immune regulation and potential therapeutics for IBD.

28 July 2025 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CXChen Xiang
Chen Xiang
APAnn Y. Park
Ann Y. Park
SWSarah E. Weber
Sarah E. Weber
MLMichael J. Lenardo
Michael J. Lenardo
AOAhmet Ozen
Ahmet Ozen
JCJing Cui
Jing Cui

12 February 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
APAnn Y. Park
Ann Y. Park
MLMichael Leney-Greene
Michael Leney-Greene
MLMatthew Lynberg
Matthew Lynberg
JGJustin Q. Gabrielski
Justin Q. Gabrielski
XXXijin Xu
Xijin Xu
MLMichael J. Lenardo
Michael J. Lenardo